"Becomes More Severe Over Time"... What is "Snowflake Disease"?

SadaNews - The term "snowflake" might seem familiar to some as a sarcastic expression used to refer to a sensitive or emotionally fragile person, but it carries a completely different meaning in the medical context. In the medical field, this name is also given to a rare and complex health condition known scientifically as "myasthenia gravis". This is a neuromuscular disease that can have profound effects, increasing over time.

According to the New York Post, this disease is not a simple matter; it leads to gradual muscle weakness and deterioration in the body’s ability to perform its normal functions, and it becomes increasingly difficult to manage as the condition develops.

Estimates indicate that between 82,000 and 85,000 adults in the United States were diagnosed with this disease in 2024, but experts believe the actual number may be higher, due to the difficulty of detection in some cases and the symptoms resembling those of other diseases.

Myasthenia gravis is an autoimmune disease that occurs when communication between nerves and muscles is disrupted, leading to progressive muscle weakness and fatigue, which often worsens throughout the day.

Typically, voluntary muscles that are under human control are affected, such as the muscles of the face, arms, legs, and throat. Weakness in these muscles can make it difficult to perform simple daily activities, such as lifting objects, walking, or even raising the head.

In about 15 percent of cases, symptoms initially present in the facial and throat muscles, leading to slurred or weak speech, difficulties in chewing or swallowing, changes in facial expressions, and in some cases, difficulty breathing.

This disease is sometimes referred to as "snowflake disease" because its symptoms vary from person to person, just as snowflakes differ in shape. Symptoms may come and go, improve with rest of the affected muscles, but return and worsen with use.

Notably, the disease is not limited to a specific age group; it can affect individuals of all ages. However, medical observations indicate that it is more common among men aged over 60, while affected women tend to be under 40 and more active.

Regarding treatment, neurologists rely on designing customized treatment plans for each patient based on the severity of the condition, the muscle groups affected, and the overall health status. Nevertheless, there is currently no definitive cure for this disease.

In this context, Gianluca Peruzzi, Head of Development, Regulatory Affairs, and Safety at Alexion, a subsidiary of AstraZeneca, stated: "The condition often worsens over time, and we have been striving for years to find ways to address the root cause of the disease."

Treatment options available include the use of various medications to manage symptoms, such as steroids - which are typically used for short periods - or cholinesterase inhibitors, which help enhance signaling between nerves and muscles and improve muscle strength.

In some cases, surgical removal of the thymus gland, which plays an essential role in the immune system's function, may be considered as a treatment option that could contribute to improving the condition in some patients.